Pfizer's stock is cheap but faces operational challenges. Analyze its valuation and performance to make informed investment ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $152.57, a high ...

Discover 10 top high-yield dividend stocks for April 2025. With a 5.30% yield & 8.33% growth rate, learn how to build wealth ...

S&P 500, Alphabet Inc Class A, Pfizer Inc, Healthcare Realty Trust Incorporated. Read 's Market Analysis on Investing.com UK.

Organizations that develop sophisticated approaches to IP risk management can protect their exit potential and create ...

Healthcare and medical manufacturing in Australia is gaining momentum with ASX companies at the forefront of growth.

Should you flee the stock market? Not at all. Instead, to protect your portfolio, here are three things every investor should do.

Pre-specified interim analysis of Phase 3 PIVOT-PO clinical trial of tebipenem HBr in complicated urinary tract infection (cUTI) is expected to ...

Detailed price information for Royalty Pharma Plc Cl A (RPRX-Q) from The Globe and Mail including charting and trades.

Pre-specified interim analysis of Phase 3 PIVOT-PO clinical trial of tebipenem HBr in complicated urinary tract infection (cUTI) is expected to be completed in Q2 2025Company expects to complete analy ...

Pfizer's top-selling product last year was Eliquis, which it co-markets with Bristol Myers Squibb. The blood thinner ...